Abstract
Body composition is a key determinant in the prognosis of patients with gastric cancer and is often associated with cachexia, a complex metabolic syndrome. Adipose tissue radiodensity, measured by computed tomography (CT), has been identified as an emerging biomarker in cancer prognosis. Additionally, the uptake of 18F-fluorodeoxyglucose (FDG) by positron emission tomography combined with…